Cyclacel Pharmaceuticals, Inc. Skyrocketed
Fri, Jul 18, 2025 at 07:31 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) jumped higher at $13.07, a gain of 58.8%. On Fri, Jul 18, 2025, CYCC:NASDAQ touched a New 2-Week High of $13.07. The stock appeared on our News Catalysts scanner on Mon, Jul 07, 2025 at 07:57 AM in the 'AGREEMENT' category. From Mon, Jul 07, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Tue, Jul 15, 2025 at $19.24 with a volume of 62M+.
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 160%
- Telomir Pharmaceuticals, Inc. (TELO:NASDAQ), 88.43%
- Incannex Healthcare Inc. (IXHL:NASDAQ), 64.82%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 58.81%
- Blaize Holdings, Inc. (BZAI:NASDAQ), 58.75%
- SRM Entertainment, Inc. (SRM:NASDAQ), 53.27%
- Expion360 Inc. (XPON:NASDAQ), 51.92%
- Stem, Inc. (STEM:NYSE), 45.63%
- Cambium Networks Corporation (CMBM:NASDAQ), 41.73%
- Celularity Inc. (CELU:NASDAQ), 37.73%